EMORY UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1836-12-10
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.emory.edu
Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2013-10-28
- Lead Sponsor
- Emory University
- Target Recruit Count
- 24
- Registration Number
- NCT00209131
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
Provigil in Conjunction With SSRIs for the Treatment of Mild or Moderate Depression With Attendant Symptoms of Sleepiness and Fatigue.
Phase 4
Completed
- Conditions
- Major DepressionMental Health
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2013-11-11
- Lead Sponsor
- Emory University
- Target Recruit Count
- 100
- Registration Number
- NCT00208715
- Locations
- 🇺🇸
Stanford University, Stanford, California, United States
🇺🇸Emory University, Atlanta, Georgia, United States
🇺🇸Mount Sinai School of Medicine, New York, New York, United States
A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-09-14
- Lead Sponsor
- Emory University
- Target Recruit Count
- 50
- Registration Number
- NCT00208949
- Locations
- 🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States
Fear Potentiation and Fear Inhibition in Posttraumatic Stress Disorder
Not Applicable
Completed
- Conditions
- Posttraumatic Stress Disorder
- Interventions
- Behavioral: Acoustic Startle Testing
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2019-08-07
- Lead Sponsor
- Emory University
- Target Recruit Count
- 425
- Registration Number
- NCT00209040
- Locations
- 🇺🇸
Atlanta VA Medical Center, Decatur, Georgia, United States
A Randomized Controlled Trial to Promote Physician-Patient Discussion of Prostate Cancer Screening
Not Applicable
Completed
- Conditions
- Prostate Cancer
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2005-09-21
- Lead Sponsor
- Emory University
- Target Recruit Count
- 250
- Registration Number
- NCT00208988
- Locations
- 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies
Phase 2
Completed
- Conditions
- Hematologic Malignancies
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-04-06
- Lead Sponsor
- Emory University
- Target Recruit Count
- 55
- Registration Number
- NCT00208923
- Locations
- 🇺🇸
Emory Universtiy Winship Cancer Institute, Atlanta, Georgia, United States
Phase II Trial of Gleevec and Taxotere as a Combined Regimen for Advanced Gastric Adenocarcinoma
Phase 2
Terminated
- Conditions
- Gastric Adenocarcinoma
- Interventions
- Drug: Gleevec, Taxotere
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2007-12-31
- Lead Sponsor
- Emory University
- Target Recruit Count
- 5
- Registration Number
- NCT00209079
- Locations
- 🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States
Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's Disease
Phase 2
Terminated
- Conditions
- B-Cell LymphomaHodgkin's Disease
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2009-05-07
- Lead Sponsor
- Emory University
- Target Recruit Count
- 2
- Registration Number
- NCT00209014
- Locations
- 🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States
Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab
Phase 2
Terminated
- Conditions
- Lymphoma
- Interventions
- Drug: Mitoxantrone/Cyclophosphamide, Fludarabine, Rituximab and GM-CSF
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-06-28
- Lead Sponsor
- Emory University
- Target Recruit Count
- 15
- Registration Number
- NCT00208975
- Locations
- 🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States
A Randomized Controlled Trial to Improve Medication Compliance Among Patients With Coronary Heart Disease
Not Applicable
Completed
- Conditions
- Coronary Disease
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- Emory University
- Target Recruit Count
- 440
- Registration Number
- NCT00208832
- Locations
- 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States